Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Juliette Murray

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Magyar Sebeszet|April 21, 2011
Imprint cytology from core biopsies increases the sensitivity of fine needle aspiration (FNA) in breast cancer patientsSanjeev Dayal, Juliette Murray, Kate Wilson, et al.
Methods in Molecular Medicine|February 24, 2006
Neoadjuvant endocrine therapy modelsJuliette Murray, William R Miller, J Michael Dixon
Annals of the Royal College of Surgeons of England|June 25, 2010
Short course pre-operative ferrous sulphate supplementation--is it worthwhile in patients with colorectal cancer?Martha Quinn, Robert J Drummond, Fiona Ross, et al.
The Journal of Steroid Biochemistry and Molecular Biology|July 19, 2005
Surgical issues surrounding use of aromatase inhibitorsJ Michael Dixon, Lorna Renshaw, Juliette Murray, et al.
Breast Cancer Research and Treatment|November 27, 2009
A study of the effects of the aromatase inhibitors anastrozole and letrozole on bone metabolism in postmenopausal women with estrogen receptor-positive breast cancerFiona M McCaig, Lorna Renshaw, Linda Williams, et al.
The Journal of Steroid Biochemistry and Molecular Biology|July 3, 2007
DCIS and aromatase inhibitorsJ Michael Dixon, Dana Faratian, Sharon White, et al.
Breast Cancer Research and Treatment|February 12, 2008
Increase in response rate by prolonged treatment with neoadjuvant letrozoleJ Michael Dixon, Lorna Renshaw, E Jane Macaskill, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2008
Letrozole suppresses plasma estradiol and estrone sulphate more completely than anastrozole in postmenopausal women with breast cancerJ Michael Dixon, Lorna Renshaw, Oliver Young, et al.
Breast Cancer Research and Treatment|September 8, 2010
Anastrozole and letrozole: an investigation and comparison of quality of life and tolerabilityJ Michael Dixon, Lorna Renshaw, Carolyn Langridge, et al.
Pharmacogenetics and Genomics|September 22, 2007
Changes in breast cancer transcriptional profiles after treatment with the aromatase inhibitor, letrozoleWilliam R Miller, Alexey A Larionov, Lorna Renshaw, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Magyar Sebeszet|April 21, 2011
Imprint cytology from core biopsies increases the sensitivity of fine needle aspiration (FNA) in breast cancer patientsSanjeev Dayal, Juliette Murray, Kate Wilson, et al.
Methods in Molecular Medicine|February 24, 2006
Neoadjuvant endocrine therapy modelsJuliette Murray, William R Miller, J Michael Dixon
Annals of the Royal College of Surgeons of England|June 25, 2010
Short course pre-operative ferrous sulphate supplementation--is it worthwhile in patients with colorectal cancer?Martha Quinn, Robert J Drummond, Fiona Ross, et al.
The Journal of Steroid Biochemistry and Molecular Biology|July 19, 2005
Surgical issues surrounding use of aromatase inhibitorsJ Michael Dixon, Lorna Renshaw, Juliette Murray, et al.
Breast Cancer Research and Treatment|November 27, 2009
A study of the effects of the aromatase inhibitors anastrozole and letrozole on bone metabolism in postmenopausal women with estrogen receptor-positive breast cancerFiona M McCaig, Lorna Renshaw, Linda Williams, et al.
The Journal of Steroid Biochemistry and Molecular Biology|July 3, 2007
DCIS and aromatase inhibitorsJ Michael Dixon, Dana Faratian, Sharon White, et al.
Breast Cancer Research and Treatment|February 12, 2008
Increase in response rate by prolonged treatment with neoadjuvant letrozoleJ Michael Dixon, Lorna Renshaw, E Jane Macaskill, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2008
Letrozole suppresses plasma estradiol and estrone sulphate more completely than anastrozole in postmenopausal women with breast cancerJ Michael Dixon, Lorna Renshaw, Oliver Young, et al.
Breast Cancer Research and Treatment|September 8, 2010
Anastrozole and letrozole: an investigation and comparison of quality of life and tolerabilityJ Michael Dixon, Lorna Renshaw, Carolyn Langridge, et al.
Pharmacogenetics and Genomics|September 22, 2007
Changes in breast cancer transcriptional profiles after treatment with the aromatase inhibitor, letrozoleWilliam R Miller, Alexey A Larionov, Lorna Renshaw, et al.
Pageof 2